
FDA officials say evidence only supports the drug's use in patients with a specific genetic disorder.
WASHINGTON (AP) The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration … [+3733 chars]









